Prioritizing therapeutic targets using patient-derived xenograft models
KA Lodhia, AM Hadley, P Haluska, CL Scott
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | ELSEVIER | Published : 2015
Awarded by National Health & Medical Research Council of Australia
Awarded by United States National Institute of Health
Awarded by Mayo Clinic SPORE in Ovarian Cancer
Awarded by Ovarian Cancer Research Fund
This work was supported by fellowships and grants from the National Health & Medical Research Council of Australia grant 1062702 (CLS) and scholarship 1076048 (AMH); the Cancer Council Victoria Sir Edward Dunlop Fellowship in Cancer Research (CLS); the Victorian Cancer Agency Clinical Fellowship (CLS); United States National Institute of Health Grants: R01 CA184502 (PH) and Mayo Clinic SPORE in Ovarian Cancer CA136393 (PH), Minnesota Partnership for Biotechnology and Medical Genomics (PH, KL) and Ovarian Cancer Research Fund OCRF258797 (PH, Kt); and Ginkgo, LLC (PH). This work was made possible through the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS and the Australian Cancer Research Foundation.